That sounds like excuses for SIRG, and lame ones at
That sounds like excuses for SIRG, and lame ones at that.
My posts are not negative...they are realistic. It's overly optimistic posts that actually cause a stock to stay low. New investors read completely unrealistic predictions, buy on those expectations, then quickly see that the predictions will never come true, and sell and move on.
I am not interested in pumping SIRG...the company and its results will do that for us. I am interested in realistic assessments of current and future state, so we don't get people jumping in and out of the stock and keeping the price down.
Because we all know what we have here, we should all want this. Bottom line is that keeping the price down radically increases the cost of funding. This is why I predict .05 as a target for 2013, and not .10 or higher. If posters were more realistic about price and timeline I believe we would attract a better class of long term investor, the s/p would rise to near fmv, funding would be significantly less expensive, and the .10 target would be more realistic. But with such high and unrealistic targets set, and those targets never being achieved, I have a lower target....for now.
Sierra Resource Group Inc (SIRG) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....
Continue Reading
Co-Diagnostics Shifts Its Calendar Well, well, well, Co-Diagnostics decided to shake up its calendar. What are they looking to spill before the weekend? They’ve bumped up their third quarter 2026 earnings release by two days—an eyebrow-raiser for folks watching NASDAQ:CODX. Now they'll lay it all out on November 10, after we wrap up the trading day. I don’t want to...
Continue Reading
Stirring Up the Shoulder Market You gotta hand it to FX Shoulder Solutions – they've managed to elbow their way into the medical device market with something truly revolutionary. With the FDA clearance of Easytech Reversed®, a stemless reverse shoulder arthroplasty system, they're not just playing the innovation game; they're setting a whole new rulebook. This isn't...
Continue Reading
Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...
Continue Reading
Five years post-tragedy, and Madison Dubiski's memory still echoes fiercely in the halls of event safety. The Pink Bows Foundation, built out of heartache and resolve, is paving the way for safer gatherings worldwide. A sound move if there ever was one, as the chaotic Astroworld Festival proved we need it. Pushing Event Safety Boundaries Pink Bows isn't just sitting on...
Continue Reading
A New Captain at the Helm Erin Denham's promotion to president of JT Mega is setting the stage for some fresh momentum in the food and beverage advertising world. This Minnesotan agency, nestled right there on Minnetonka Boulevard, has been an independent force for five decades. It's a sector dominated by players who often get absorbed by the behemoth holding companies,...
Continue Reading
Chesapeake Utilities Shows Strong Q3 2026 Growth Chesapeake Utilities Corporation (NYSE: CPK) ain't pulling any punches this quarter. They're showing off some solid numbers, with net income for Q3 hitting $21.6 million and EPS coming in at $0.89. Not just stopping there, these fellas are flexing a year-to-date growth rate of 8.4% on Adjusted EPS. Now, you gotta pay...
Continue Reading
Remote Fetal Monitoring: A Game Changer in Prenatal Care? In the world of high-risk pregnancies, routine checkups aren't just a suggestion—they're vital. But when the logistics of shuttling back and forth to clinics get tangled with everyday life, something's gotta give. Enter Nuvo's INVU™. The REACTIVE trial, a Penn Medicine-led event funded by the NIH, aimed to see...
Continue Reading
Transforming Security Assessments with SensAI Security screenings are about to get a serious upgrade with SensAI Veritas rolling out their latest toys—the SensAI Gateway™ and Helm™. Forget what you knew about traditional identity checks; this is all about diving deeper to sniff out those hidden risks before anyone gets a green light. From Static Checks to Dynamic...
Continue Reading
The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...
Continue Reading
Top 5 Most Recently Viewed Articles
Shashi Upadhyay Named President of Product, Engineering, and AI Zendesk has recently appointed Shashi Upadhyay as the new President to lead Product, Engineering, and AI initiatives. His role aims to propel the company into a new era, focusing on elevating customer and employee services. With a wealth of experience in technology and product leadership, Upadhyay is expected...
Continue Reading
Tesla Model Y Discounts Before New Launch Tesla Inc. is making headlines by offering significant discounts on its Model Y SUV, providing buyers an opportunity to save up to $7950. As excitement builds around the impending launch of the refreshed version of the Model Y, many are scrambling to take advantage of the pricing adjustments underway. What You Need to Know About...
Continue Reading
Nokia Teams Up with Spark to Boost 5G Infrastructure Nokia is thrilled to announce that Spark has chosen it as the key partner for its 5G Radio Access Network (RAN) expansion project in New Zealand. This collaboration is crucial for enhancing Spark's ability to modernize and optimize its network operations, ensuring customers can enjoy a superior 5G experience. Enhancing...
Continue Reading
Crown Electrokinetics Secures Significant Contracts Crown Electrokinetics Corp, trading under the ticker CRKN, has recently experienced a significant uptick in its stock value. This increase follows the announcement of two substantial contracts awarded to its PE Pipelines division, which together amount to an impressive $33 million. These contracts specifically target the...
Continue Reading
Recent Trends in Alnylam Pharmaceuticals Inc's Short Interest Alnylam Pharmaceuticals Inc (NYSE: ALNY) has recently seen a 5.53% decline in short interest. According to the latest data, the current short interest stands at 3.51 million shares sold short, accounting for approximately 3.59% of its total float. This indicates a significant amount of stock available for...
Continue Reading